Stay ahead of regulatory change. Our experts track developments across FDA, EU, ECHA and global frameworks so you don't have to.
The updated notification portal goes live Q3 2026, affecting all cosmetic products containing nanomaterials. Companies must update submissions by September or face market withdrawal. …
The CARES Act provisions are reshaping how over-the-counter drug products are regulated, with significant implications for ongoing reformulation projects. …
ECHA has added five substances of very high concern to the candidate list, prompting urgent compliance reviews for fragrance and industrial chemical manufacture…
The revised Annex 1 to EU GMP guidelines introduces significant changes to contamination control strategy requirements for manufacturers across Europe. …
GCC markets present significant growth opportunities but require specific registration steps through the GSO and national health authorities. …